The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally
The investment will enable the company to enter European markets as well as enhance margins in current markets
Sanjeev is currently the Country President for AstraZeneca Malaysia
The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
Results are the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial
This was a pre-approval inspection to cover our Oncology Injectable drug products for which ANDAs were filed with USFDA
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
He is a seasoned leader with 34 years of rich and diverse experience across geographies and consumer facing companies such as Xerox India and Bharti Airtel
Subscribe To Our Newsletter & Stay Updated
